Aspiro Therapeutics Establishes Advisory Board to Support Development of Lead Therapy
Tucson, Arizona / June 11, 2025 — Aspiro Therapeutics, a preclinical-stage biopharmaceutical company pioneering the development of groundbreaking, disease-modifying therapies for obstructive lung diseases, today announced the strategic addition of two new advisors: Matt Britz and Dr. Anne Dixon. Their combined leadership in respiratory science, clinical development, and biotech company building will significantly support Aspiro’s […]